How to Improve CRO Data Management
Read this fact sheet to learn how Pinnacle 21 Enterprise improves CRO data management and…
CertaraMarch 23, 2026
Leveraging the full potential of PBPK models to accelerate drug development
Explore how Novartis applies PBPK modeling in drug development using Simcyp to support regulatory decisions,…
CertaraMarch 20, 2026
From Numbers to Narrative: Mastering the Art of PK Presentation
Master PK data reporting with a structured guide to presenting pharmacokinetic results clearly and turning…
CertaraMarch 20, 2026
What are Common Bioequivalence Study Mistakes?
Learn about the most common bioequivalence study mistakes drug developers make and the differences between…
CertaraMarch 20, 2026
Pediatric Drug Development and Pharmacometrics: Key Questions Sponsors Must Answer
Download Certara’s expert guide on pharmacometrics and pediatric drug development. Learn how modeling, MIDD, and…
CertaraMarch 19, 2026
Rethinking Trial Design With Bayesian Approaches
Learn how Bayesian approaches are transforming clinical trial design by enabling adaptive studies, data borrowing,…
CertaraMarch 19, 2026
The future of payer engagement in pharma: rethinking how value is communicated
A detailed analysis of strategies for payer engagement in pharma and how digital payer engagement…
CertaraMarch 19, 2026
What is GLP (Good Laboratory Practice)?
Read this blog to understand GLP (Good Laboratory Practice) and associated QA audits, and proper…
CertaraMarch 18, 2026
ICH M15 Guideline: What the Finalized Guideline Means for Model-Informed Drug Development
With the release of the draft ICH M15 guidance, MIDD is no longer optional -…
CertaraMarch 18, 2026
